LifeMD Inc [LFMD] stock is trading at $6.55, up 2.99%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LFMD shares have gain 12.35% over the last week, with a monthly amount glided 4.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
LifeMD Inc [NASDAQ: LFMD] stock has seen the most recent analyst activity on June 18, 2025, when BTIG Research reiterated its Buy rating and also boosted its price target to $18 from $15. Previously, Lake Street started tracking the stock with Buy rating on December 10, 2024, and set its price target to $12. On December 04, 2024, Mizuho initiated with a Neutral rating and assigned a price target of $7 on the stock. KeyBanc Capital Markets initiated its recommendation with a Overweight and recommended $12 as its price target on June 05, 2024. Craig Hallum started tracking with a Buy rating for this stock on November 30, 2023, and assigned it a price target of $10. In a note dated July 21, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $7 on this stock.
LifeMD Inc [LFMD] stock has fluctuated between $3.99 and $15.84 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. LifeMD Inc [NASDAQ: LFMD] shares were valued at $6.55 at the most recent close of the market. An investor can expect a potential return of 174.81% based on the average LFMD price forecast.
Analyzing the LFMD fundamentals
LifeMD Inc [NASDAQ:LFMD] reported sales of 245.56M for the trailing twelve months, which represents a growth of 22.81%. Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is 1.55 and Total Capital is 0.55. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -12.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.35 points at the first support level, and at 6.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.68, and for the 2nd resistance point, it is at 6.80.
Ratios To Look Out For
For context, LifeMD Inc’s Current Ratio is 0.77. Further, the Quick Ratio stands at 0.72, while the Cash Ratio is 0.57. Considering the valuation of this stock, the price to sales ratio is 1.26.
Transactions by insiders
Recent insider trading involved Alvarez Nicholas P, Chief Acquisition Officer, that happened on Sep 10 ’25 when 75000.0 shares were sold. Officer, Alvarez Nicholas P completed a deal on Sep 10 ’25 to buy 75000.0 shares. Meanwhile, Chairman and CEO Schreiber Justin sold 25000.0 shares on Jul 01 ’25.
